Cite
HARVARD Citation
Yiu, Z. et al. (2019). Infliximab is associated with an increased risk of serious infection in patients with psoriasis in the U.K. and Republic of Ireland: results from the British Association of Dermatologists Biologic Interventions Register (BADBIR). British journal of dermatology. pp. 329-337. [Online].